Coverage
-
May 19, 2017
Derma Sciences Inc. shareholders on Friday agreed to drop a putative class action seeking to block Integra LifeSciences Holdings Corp.'s $204 million proposal to buy the tissue regeneration company, telling a New Jersey federal judge that supplemental regulatory disclosures have rendered the claims moot.
1 other articles on this case.
View all »